IL13RA2在甲状腺乳头状癌与滤泡状癌中的差异调控
该研究对137例甲状腺癌组织芯片进行IL13RA2免疫组化染色,并在细胞系中验证其差异表达。结果显示IL13RA2表达与晚期T分期和淋巴结转移相关,在乳头状癌中显著高于滤泡状癌,且通过增强上皮间质转化促进细胞迁移。
要点
- IL13RA2表达与甲状腺癌晚期T分期(pT3/pT4)和区域淋巴结转移(pN1)显著相关。
- IL13RA2在乳头状癌中的染色评分显著高于滤泡状癌(P<0.001)。
- IL13RA2通过增强上皮间质转化(EMT)促进乳头状癌细胞迁移。
核心结论
- IL13RA2在甲状腺乳头状癌与滤泡状癌中差异调控,并通过增强EMT参与细胞迁移。
研究设计与样本
- 对137例甲状腺癌患者的组织芯片进行IL13RA2免疫组化染色,并在甲状腺癌细胞系中验证差异表达。
- 在乳头状癌细胞系中使用CCK-8、Transwell迁移实验、定量RT-PCR和Western blot评估IL13RA2下调和过表达对增殖、迁移及EMT的影响。
主要发现
- IL13RA2表达与晚期肿瘤T分期(pT3或pT4;P=0.001)和区域淋巴结转移(pN1;P<0.001)显著相关。
- 乳头状癌中IL13RA2染色评分显著高于滤泡状亚型(P<0.001),且在乳头状癌样本中与晚期肿瘤分期相关(pT3或pT4;P=0.028)。
- 在B-CPAP细胞中敲低IL13RA2显著降低细胞活力、细胞迁移及EMT标志物(N-cadherin、Vimentin、Snail)。
- 在K1细胞中外源性过表达IL13RA2增加细胞迁移和EMT,但细胞增殖未受影响。
临床怎么用
- IL13RA2表达水平可能有助于区分乳头状癌与滤泡状癌,并提示晚期分期和淋巴结转移风险。
- IL13RA2-EMT轴可能作为乳头状癌进展的潜在干预靶点,但尚需进一步临床验证。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
CONTEXT: The interleukin-13 receptor alpha2 (IL13RA2), which is known to be overexpressed in glioblastoma multiforme, plays a role in various cellular processes such as cell migration that may contribute to tumor progression. Studies have attributed IL13RA2 to invasion and metastasis in cancers of the ovary, breast, and pancreas, but the pathological role of IL13RA2 in thyroid cancer is still unclear. OBJECTIVE: This study aims to evaluate IL13RA2 expression in thyroid carcinomas and to examine the role of IL13RA2 in the progression of papillary thyroid carcinoma (PTC). METHODS: IL13RA2 immunochemical staining was performed on tissue microarrays of 137 thyroid carcinomas from patients, and the differential profile of IL13RA2 was validated in thyroid cancer cell lines. In PTC cell lines, we functionally assessed the effects of IL13RA2 underexpression and overexpression on cell proliferation, cell migration, and epithelial-mesenchymal transition (EMT) by using CCK-8, transwell migration assay, quantitative RT-PCR, and Western blot analysis. RESULTS: IL13RA2 expression was significantly correlated with advanced tumor T stage (pT3 or pT4; P = 0.001) and regional lymph node metastasis (pN1; P < 0.001). The staining scores of IL13RA2 were significantly higher in PTC compared with follicular subtypes (P < 0.001) and correlated with advanced tumor stage among PTC samples (pT3 or pT4; P = 0.028). Knockdown of IL13RA2 in B-CPAP cells significantly reduced cell viability, cell migration, and EMT markers including N-cadherin, Vimentin, and Snail. Exogenous overexpression of IL13RA2 in K1 cells increased cell migration and EMT, although cell proliferation was not affected. CONCLUSION: IL13RA2 is differentially regulated in PTC and is involved in cell migration by enhancing EMT.
引用
- Chong ST, Tan KM, Kok CYL, et al. IL13RA2 Is Differentially Regulated in Papillary Thyroid Carcinoma vs Follicular Thyroid Carcinoma. J Clin Endocrinol Metab. 2019. PMID: 31290966. doi:10.1210/jc.2019-00040
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。